Pacira BioSciences, Inc. — Director's Dealing 2021

Jun 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-06-09

Reporting Person: Kronenfeld Mark A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-09	Common Stock	A	1066	$0.00	Acquired	16737	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-09	Stock Option (Right to Buy)	$60.96	A	7626	Acquired	2031-06-09	Common Stock (7626)	Direct

Footnotes

F1: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.